Pharming « Terug naar discussie overzicht

Voor ons allen: een belangrijk bericht van Pharming

10 Posts

Omlaag ↓

[verwijderd] 1 januari 2010 12:07

Pharming wishes you a prosperous and a successful 2010!

Pharming wenst u een succesvol en gelukkig 2010!

[verwijderd] 1 januari 2010 12:11

Pharming Group is putting the troubles of the last few years behind it. Rhucin’s formulation for hereditary angioedema (HAE) gives better efficacy than plasma-derived competitors. The US market has established HAE reimbursement and a $3,900 per dose price. The new preclinical data on Rhucin in managing ischemic side-effects supports large potential follow-on indications. The first indication will be the alleviation of damage to transplanted organs; Pharming is preparing exploratory clinical trials. The debt burden has been cut to €10.9m with a 6.875% coupon.

[verwijderd] 2 januari 2010 10:22

Pharming Group N.V. Acquires Licenses to Fibrinogen Patents
Pharming Group N.V announced that it has obtained exclusive licenses on recombinant fibrinogen for all indications in various territories, including North America, Europe and Japan, from GTC Biotherapeutics Inc (GTC). The licenses are for recently issued patents owned by the American Red Cross, Virginia Tech Intellectual Properties Inc and the University of North Carolina on the production of recombinant fibrinogen in milk of transgenic animals which are licensed to GTC from ProGenetics, LLC. The license agreement includes an upfront payment to GTC of approximately EUR 350,000 and a royalty on commercial sales of recombinant human fibrinogen.

[verwijderd] 2 januari 2010 10:30

quote:
Hanna Tokkie schreef:
Pharming Group N.V. Acquires Licenses to Fibrinogen Patents
Pharming Group N.V announced that it has obtained exclusive licenses on recombinant fibrinogen for all indications in various territories, including North America, Europe and Japan, from GTC Biotherapeutics Inc (GTC). The licenses are for recently issued patents owned by the American Red Cross, Virginia Tech Intellectual Properties Inc and the University of North Carolina on the production of recombinant fibrinogen in milk of transgenic animals which are licensed to GTC from ProGenetics, LLC. The license agreement includes an upfront payment to GTC of approximately EUR 350,000 and a royalty on commercial sales of recombinant human fibrinogen.

Hanna van welke datum is dit bericht?

Ruud..

[verwijderd] 2 januari 2010 12:10

2 januari 2010

[verwijderd] 2 januari 2010 12:11

The licenses are for recently issued patents owned by the American Red Cross, Virginia Tech Intellectual Properties Inc and the University of North Carolina on the production of recombinant fibrinogen in milk of transgenic animals

Hier gaat het om.

aextracker 2 januari 2010 12:27

Maar de "officiele bron van dit bericht en publicatie datum waarop de bron het bericht publiceerde is" ?

Tracker

[verwijderd] 2 januari 2010 12:35

Pharming has obtained exclusive licenses on recombinant fibrinogen for all indications in various territories, including North America, Europe and Japan. The licenses are to recently issued patents owned by the American Red Cross, Virginia Tech Intellectual Properties Inc and the University of North Carolina on the production of recombinant fibrinogen in milk of transgenic animals which are licensed to GTC from ProGenetics, LLC. The license agreement includes an upfront payment to GTC of approximately € 350,000 (US$ 550,000) and a royalty on commercial sales of rhFIB. Pharming already owns several additional patents and licenses for recombinant fibrinogen and recombinant tissue sealant compositions. The acquisition of the license from GTC further broadens and strengthens Pharming’s position in this field.

Dit berichtje is uit een draadje van 25-06-2008.
Welke datum kan jij er aan plakken

Gijs

[verwijderd] 2 januari 2010 14:37

En Hanna Tokkie komt nu op het lijstje waarheidverdraaiers op het Pharming forum.

E.

[verwijderd] 2 januari 2010 15:52

Sterker nog, Tokkie moet in ´t Hokkie!!

10 Posts

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd	14 jun 2024 17:35
Koers	0,743
Verschil	-0,007 (-1,00%)
Hoog	0,759
Laag	0,743
Volume	2.937.440
Volume gemiddeld	6.027.703
Volume gisteren	3.043.910

Pharming nieuws

31 mei	Slotcall: AEX struikelt voor de finis...
31 mei	Tegenslag bij EMA resulteert in tijdv...	1
30 mei	Europese goedkeuring voor leniolisib ...	1
21 mei	Jaarvergadering Pharming akkoord met ...	1
10 mei	RBC verlaagt koersdoel Pharming
08 mei	Update: Flinke omzetstijging Pharming	2
08 mei	AEX houdt 900 punten waarschijnlijk n...	2
19 apr	Pharming lost voor 123 miljoen euro a...
18 apr	Pharming rondt plaatsing obligaties af	5
18 apr	Pharming vervangt converteerbare lening	6

Meer ››